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Objective. To report our successful treatment of acute symptoms of posttraumatic stress disorder (PTSD). By the use of stellate
ganglion block (SGB) and pulsed radiofrequency (PRF) to the stellate ganglion(SG) , sequentially. Background. A 48-year-old
male a victim of armed robbery , who presented with extreme symptoms consistent with the diagnosis of PTSD. He was treated
with antianxiety medications, as well as psychotherapy, but his symptoms persisted. Methods. Fifty-ﬁve days post trauma, we
administered a SGB to the patient. One month later, we administered PRF to the right SG . We repeated the pulsed radiofrequency
30 weeks post trauma and performed a second SGB two weeks after that. Results. After the SGB , the patient experienced a major
reduction in anxiety. Over the next week his improved allowing a signiﬁcant reduction of antianxiety medications. One month
later the symptoms returned and again subsided substantially following PRF , and that relief lasted four months. The patient
than required another following PRF and a SGB with good responses. Conclusion. We report that selective blockade of the stellate
ganglion via injection and the treatment with PRF, relieved our patient’s symptoms of PTSD. And we also provide a plausible
explanation of the eﬀect.
1.Introduction
Posttraumatic stress disorder (PTSD) is a pathological anxi-
ety that occurs when an individual experiences or witnesses
severe trauma that constitutes a threat to his/her physical
integrity or that of another person. The individual initially
responds with intense fear, a sense of helplessness, or horror;
later he or she may reexperience the event, with resultant
symptoms of numbness, avoidance, hypervigilance, and
hyperarousal. These symptoms lead to clinically signiﬁcant
distress and/or functional impairment [1].
The reported incidence of PTSD is increasing—in part,
due to improved recognition, but also as a result of recent
large-scale military and civilian traumatic events in the
world. Despite the fact that PTSD is the most commonly
diagnosed service-related mental disorder among U.S. mil-
itary personnel returning from Iraq and Afghanistan, an
expert panel convened by the Institute of Medicine found
little evidence for the eﬃcacy of most currently employed
PTSDtreatmentmodalities[2].Becauseofitsprevalenceand
the severe disability that can be associated with it, there is an
urgent need for eﬀective PTSD treatments.
2.CaseReport
A 48-year-old male was the victim of an armed robbery at
the auto parts store he manages. The patient reported that
robbers assaulted him as he was closing the store for the
night, tied him up in the back of the store, held a handgun
to his head, and hit him “with the gun over 100 times in
the head.” He sustained minor, closed soft-tissue injuries,
swelling, and bruising, which healed without treatment. One
week post trauma the patient presented to his primary care
physician with severe anxiety. He denied physical pain but
reported having sporadic attacks of nausea, shaking, loss
of appetite, and insomnia. He was prescribed escitalopram
10mg/day, alprazolam 0.5mg 4–6 times/day, and olanzapine
20mg at bedtime.2 Pain Research and Treatment
Twenty-three days post trauma, the patient complained
that the medications had not provided much relief. At
that time, he underwent evaluation by a neuropsychologist
with expertise in PTSD. During the assessment, the patient
described feeling as if he had “too much adrenalin”, reported
having intermittent chest tightness (“like I’m having a
heart attack”), said he was still experiencing insomnia and
nightmares, and mentioned that he had resumed smoking
cigarettes (10 to 15 per day), after having quit smoking ten
years earlier. Based on these complaints and a thorough
medical/psychiatric history, the neuropsychologist diag-
nosed PTSD. He noted that the patient’s presentation was
tearful and marked by extreme anxiety and vigilance, which
included motoric agitation, poor eye contact, restlessness,
and distractibility. He recommended psychotherapy, which
the patient agreed to.
Owing to the severity of his physiological symptoms of
anxiety, the patient’s psychotherapy (with the neuropsychol-
ogist who evaluated him) began with relaxation training,
which included listening to a progressive relaxation tape at
home a few times a day. The patient found the tape helpful
at ﬁrst, but after a few weeks he experienced no further gains
and said that he continued to have days when he felt like he
was “going 110 miles per hour.”
The patient continued in psychotherapy, but his anx-
iety worsened. He was referred to our pain center as a
potential alternative to psychiatric admission. Fifty-ﬁve days
post trauma, with the patient’s full written consent, we
administered a right-sided stellate ganglion block. His neck
was anesthetized with 2cc lidocaine 2%. We then placed
a 22-guage Quincke needle to the anterolateral aspect of
the C6 vertebra under ﬂuoroscopy. The needle contacted
the bone and was pulled back 1mm. This was followed
by injection of 3cc of iohexol (180mg/mL) to visualize
the ganglion and conﬁrm needle placement, as well as to
rule out intravascular, subarachnoid, or other inappropriate
spread. Then 7cc of 0.5% bupivacaine was injected next
to the stellate ganglion to produce a sympathetic block.
We monitored the patient’s hand temperature during the
anesthetic administration and noted a 2◦C increase in the
right hand; he also had facial anhidrosis and Horner’s
syndrome (i.e., enophthalmos, ptosis, swelling of the lower
eyelid, miosis, and heterochromia)—all are evidence of a
successful block.
Immediately following the procedure, the patient said
that he felt no anxiety. Over the next month, he kept a diary
of his symptoms.
On Day 1 post SGB, the patient reported having some
diﬃculty concentrating. He went out to dinner that evening
with family and said that he “ate more food that night than
I had eaten in a week.” That night he slept for 4 continuous
hours.
On Day 3, he had an episode of chest tightness, which
was alleviated by alprazolam. He saw his psychologist, who
was struck by a marked reduction in the patient’s vigilance.
He was “able to sit rather than having to stand and walk
as he talked” and “had normal eye contact.” The patient
commented, “At least I do not feel like I’m running at 110
miles per hour.” That night he slept soundly for 5 hours.
He experienced two acute anxiety episodes per day
on Days 4 and 5, which were relieved by alprazolam; he
continued to eat well. On Day 6, he took 0.50mg alprazolam
upon awakening but did not take a second dose because he
had an anxiety-free day.
One week post SGB, he reported 80% to 90% improve-
ment in his anxiety level, 50% improvement in his appetite,
and 25% improvement in his sleep.
We saw the patient again on Day 32 (twelve and half
weeks post trauma), at which time he complained that his
symptoms had returned. In particular, he noted that his
appetite was gone and his nightmares had come back. At that
time, we obtained his written consent to administer pulsed
radiofrequency (PRF) current to the right stellate ganglion.
He was placed in a supine position on the procedure table
with a shoulder roll. The right side of his neck was prepared
with povidone-iodine and sterile drapes, and the skin was
anesthetized. We then directed a 22-gauge, 10cm insulated
needle with a 10mm, 42
◦C active tip to the sixth cervical
vertebra, placing it in the anterior lateral position; this
was conﬁrmed by ﬂuoroscopy. We used a 500kHz current,
applied at 2 bursts per second, with each burst lasting 20
milliseconds, for a total of 360 seconds. We monitored
his right-hand temperature during the application, but
no change was noted. After the procedure, he reported
immediate relief (“a downshift from 5th to 1st gear”); his
appetite improved that day, as did his sleep that night.
One month later, the patient said that he was still “90%
improved.”
Four months following PRF, the patient’s symptoms
returnedagain.WerepeatedthePRF,andheexperiencedtwo
weeks of relief. Then we repeated the SGB, which provided
almost complete relief from most of his PTSD symptoms for
one month; over the next few weeks he estimated that he was
functioning at about 70% of his pretrauma level. Although
the patient was on the verge of psychiatric hospitalization
when he started his treatment with us, he has not been, nor
has he needed to be admitted.
3. Discussion
A literature search revealed no published reports on the use
of either SGB or PRF in PTSD. The usual indication for
SGB and PRF is complex regional pain syndrome (CRPS).
Although CPRS was formerly known as reﬂex sympathetic
dystrophy, recent studies point to central mechanisms for
both its sensory and autonomic features [3]. PTSD is also
to a large extent centrally mediated [1, 4, 5]. Grande et al.
described the acute onset of CRPS in a patient with PTSD;
they interpreted the CRPS as a stress response. The clinical
association of the two conditions suggested shared neural
substrate elements; they hypothesized that the patient’s
CRPSresulted froma dysfunctional relationship between the
periaqueductal gray, a midbrain structure that coordinates
defensive responses, and the anterior cingulate cortex in the
forebrain, which is active in emotional processing [6].
3.1. Central-Sympathetic Connections. Our choice of
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ganglion—was based partially on reports of successful
endoscopic sympathetic block (ESB), that is, clipping of
the sympathetic ganglia at the level of the second thoracic
vertebra, for the treatment of severe anxiety and social
phobia [7–9]. Telaranta, a pioneer of that treatment,
has noted that social phobia and PTSD share many
common features—most notably symptoms associated with
overactivity of the sympathetic nervous system (SNS), such
as heart racing, hypervigilance, and avoidance of painful
psychic situations. [8]. At the same time, ESB of the thoracic
ganglia and SGB are comparable sympathetic interventions.
In fact, many of the eﬀerent sympathetic ﬁbers from the
thoracic ganglia pass through the stellate ganglion [10],
and the T2 ramus communicans is a known connection
between the upper thoracic ganglion and the stellate [11].
Interestingly, both SGB and ESB have been used successfully
for the treatment of schizophrenia, a condition at least
partially characterized by exaggerated responses to external
stimuli [1, 12, 13]. Based on these ﬁndings and insights, we
speculated that manipulation of the neuronal circuitry in
the neck connecting the SNS with key perception centers in
the brain via SGB, then PRF, might reset those connections
to a pretrauma state, thereby alleviating the patient’s
symptoms.
Further objective evidence in support of these blocks
comes from transsynaptic tracing methodology—the use of
live viruses to label chains of neurons which has made it
possible to delineate central eﬀerents that regulate sympa-
thetic targets [14, 15]. Utilizing pseudorabies virus injections
in rats, Westerhaus and Loewy found that four cortical
regions—insular, infralimbic, ventromedial temporal, and
ventral hippocampal—were linked via multisynaptic con-
nections to three sympathetic targets—the stellate ganglion,
adrenal gland, and celiac ganglion [16]. The authors specu-
lated that dysfunction in those central-sympathetic circuits
may lead to exaggerated autonomic responses, including the
extreme anxiety associated with PTSD [16].
The insular cortex has been shown to play a pivotal
role in the pathophysiology of CRPS and PTSD [3, 5, 17].
Using voxel-based morphometry, Chen et al. demonstrated
that survivors of a ﬁre disaster with diagnosed PTSD had
reduced gray matter volume in the insular cortex as well as
in the hippocampus and anterior cingulate cortex compared
with survivors of the same ﬁre without PTSD [4]. Animal
research related to PTSD has shown that repeated stress
causes basolateral amygdala neurons to increase in dendritic
complexity and sprout new synapses [5]. The hippocampus,
which plays a role in memory and learning, receives input
from the amygdala, and its function in spatial memory is
altered by amygdala activity [5]. These neural changes may
contribute to the altered autonomic responses (including
increased fear) seen in PTSD. Positron emission tomography
(PET)studiesofpatientswithPTSDhaveshowndysfunction
in the prefrontal cortex during symptom provocation and
in response to traumatic reminders [18]. Bremner has sug-
gested that dysfunction in the hippocampus and prefrontal
cortex, both consistently implicated in PTSD, may under-
lie memory deﬁcits and pathological emotions in PTSD
[18].
3.2. SNS Dysfunction. PTSD can lead to overactivity of the
adrenal glands [19], which is consistent with our patient’s
reports of “too much adrenalin” and “going 110 miles per
hour.” As Westerhaus and Loewy showed, the adrenal glands
and stellate ganglion have common connections with the
cerebral cortex [16]. The hypervigilance associated with
PTSD may be due to overactivation of the adrenals in
particular and of the SNS in general. We speculate that
SGB and PRF may reduce the adrenal output and relieve
symptoms via a “rebooting” of the aforementioned central-
sympathetic connections.
Sleep disturbance is common in PTSD and was a recur-
ringcomplaintofourpatient.Thecausemaybeamelatonin-
related mechanism associated with the sympathetic system.
Uchida et al. proposed that melatonin-related dysrhythmias,
including sleep disorders, may be the result of chronically
increased sympathetic nerve tone, which eventually causes
decreased functioning of pinealocytes and reduced plasma
melatonin levels. SGB, they suggest, may interrupt the
sympathetic cycle, thereby allowing the normal melatonin
rhythm to be reestablished [10].
3.3. PRF As an Alternative to SGB. PRF has gained popu-
larity as an alternative to conventional radiofrequency (RF)
treatment and is increasingly used to manage pain syn-
dromes [20–22]. Unlike RF, which delivers continuous high-
temperature (∼85◦C) current, PRF delivers high-intensity
current in pulses; during each cycle, an active phase of
20 milliseconds is followed by a silent phase of 480ms,
which allows heat to dissipate, so that neurodestructive
temperatures are not reached [22].
PRF may be used in place of local anesthetic in a
variety of nerve blocks—including SGB—and usually pro-
vides longer-lasting eﬀects [23]. Although its mechanism
has not been fully elucidated, Cahana et al. concluded,
after reviewing all the published clinical and laboratory
data on PRF, that it involves “a genuine neurobiological
phenomenon altering pain signaling” [21]. In the same
publication Dr. Cahana reported that in his experience and
literature review no complications have been associated with
the use of pulsed radiofrequency. This was the reason for
the substitution of PRF for SGB after one local anesthetic
block in our patient. The usual convention is to do multiple
Stellate Ganglion Blocks prior to a neurolytic or more
permanent block. However we believe that the PRF is not
neurolytic, is less dangerous than SGB, and may have longer
eﬀects.
One theory for PRF’s eﬀects focuses on the upregulation
of c-Fos, a marker of neuronal activity. In rats, PRF activates
c-Fos in the dorsal horn; this expression is seen immediately
and for up to seven days post PRF—far longer than would
be expected as a direct eﬀect of the applied current [21,
24]. The duration of c-Fos immunoreactivity may be the
result of the inhibition of excitatory C-ﬁber responses [24].
Another theory is that PRF creates an electromagnetic
ﬁeld that depolarizes and disrupts nerve cell membranes
via selective deactivation of small-diameter nerve ﬁbers
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3.4. Right- versus Left-Sided Blocks. We administered a right-
sidedSGBandsubsequentlyPRFtotherightstellateganglion
becauseright-sidedblocksaﬀectrighthemispherestructures,
and, pertinent to PTSD, it is well established that the
right hemisphere is responsible for producing autonomic
responses to emotional stimuli, and the right amygdala
is critically linked to unconscious emotional memories,
whereasthelefthemisphereisnotinvolvedinthoseprocesses
[25]. PET studies of Vietnam veterans with combat-induced
PTSD have demonstrated increased regional cerebral blood
ﬂow (rCBF) in the right amygdala [26]; moreover, PTSD
symptom severity appears to be positively related to rCBF
in the right amygdala [27] but not to blood ﬂow in the
left amygdala. Imaging studies have also shown that patients
with PTSD have signiﬁcant reductions in right hippocampal
volume [18, 28, 29] and that neuronal density in right-sided
medial temporal structures is signiﬁcantly reduced [29].
4. Conclusion
Multiple CNS structures that are neuronally connected to
the SNS appear to play a role in the onset and mainte-
nance of PTSD. Recent advances in functional MRI and
labeling techniques have enhanced our understanding of
the neuroanatomy and allowed us to formulate a plausible
explanation for the central eﬀects of SGB and PRF in a
patient with acute PTSD. It is important to note that,
unlike existing treatments for PTSD, SGB and PRF provide
virtually immediate results. We believe that further inves-
tigation of these interventions is warranted, as they may
providewelcomealternativesand/orcomplementstocurrent
psychological and pharmacological treatments for PTSD,
an increasingly prevalent condition in both military and
civilian populations. We would like to introduce a new term
“Chicago Block” which would designate that use of a cervical
sympathetic block on the right side at C6 level. Technically
stellateganglionblockisduneatC7(onecervicallevellower)
and bilateral.
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